Viral Clearance Market Report 2026

Viral Clearance Market Overview

• Viral Clearance market size has reached to $0.96 billion in 2025 • Expected to grow to $2.06 billion in 2030 at a compound annual growth rate (CAGR) of 16.4% • Growth Driver: Rising Prevalence Of Chronic Diseases Fueling Growth Of The Market Due To Increasing Demand For Safe Biologics And Gene Therapies • Market Trend: Advancing Biologics Safety Through Technological Innovation • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Viral Clearance Market?

Viral clearance is the process of detecting and removing or inactivating viruses from biological products to ensure they are free from viral contamination. It involves a series of steps such as filtration, chemical treatment, or heat inactivation. The primary purpose is to ensure the safety and purity of products by minimizing the risk of virus transmission. The main methods of viral clearance include viral clearence, viral removal, viral inactivation, and viral detection. Viral clearance techniques aimed at eliminating potential viral contaminants from biological products. These methods are applied across various areas such as vaccines and therapeutics, blood and blood products, cellular and gene therapy products, tissue-based products, and others, catering to end users including pharmaceutical and biotechnology companies, contract research organizations (CROs), academic research institutes, and others.

What Is The Viral Clearance Market Growth Forecast?

The viral clearance market size is expected to see rapid growth in the next few years. It will grow to $2.06 billion in 2030 at a compound annual growth rate (CAGR) of 16.4%. The growth in the forecast period can be attributed to development of next-generation viral inactivation methods, rising adoption of nanofiltration and membrane chromatography, increasing biologics and gene therapy production, integration of automation in viral clearance workflows, growing investment in viral detection assay development. Major trends in the forecast period include increasing adoption of advanced viral detection and inactivation methods, rising demand for safe and virus-free vaccines and therapeutics, expansion of cellular and gene therapy products requiring viral clearance, integration of high-efficiency filtration and nanofiltration technologies, growing outsourcing to contract research organizations for viral clearance services.

What Is The Driver Of The Viral Clearance Market?

The rising prevalence of chronic diseases is expected to propel the growth of the viral clearance market going forward. Chronic diseases are ongoing medical conditions that develop over time and last for months or years, often requiring continuous care or management. The prevalence of chronic diseases is increasing globally, primarily driven by aging populations, as people live longer due to improvements in healthcare and living standards, leading to a rise in age-related conditions such as cardiovascular diseases, diabetes, arthritis, and cancer. Viral clearance is crucial in developing biologics and gene therapies used to treat chronic diseases, ensuring their safety and effectiveness. For instance, in June 2023, the Institute for Health Metrics and Evaluation, a US-based public health research institute, reported that over half a billion people globally were living with diabetes. This number is expected to more than double, reaching 1.3 billion people by 2050. Therefore, the rising prevalence of chronic diseases is driving the growth of the viral clearance industry.

Key Players In The Global Viral Clearance Market

Major companies operating in the viral clearance market are Merck Group, Thermo Fisher Scientific Inc., Asahi Kasei Corporation, SGS SA, Eurofins Scientific Inc., Lonza Group AG, WuXi AppTec, Catalent Biologics, Charles River Laboratories, Nelson Labs, Pall Corporation, Sartorius AG, Creative Biolabs, Texcell SA, Vironova AB.

Global Viral Clearance Market Trends and Insights

Major companies operating in the viral clearance market are focusing on developing innovative products such as next-generation virus removal filters to enhance viral safety and improve biopharmaceutical manufacturing efficiency. Next-generation virus removal filters are advanced filtration devices designed to efficiently remove viruses from biopharmaceutical products, helping to ensure product safety, increase filtration speed, and support higher productivity in drug manufacturing. For instance, in October 2024, Asahi Kasei Medical Co., Ltd., a Japan-based medical and bioprocess solutions company, launched its next-generation Planova FG1 virus-removal filter, which offers roughly seven-times higher flux than Planova BioEX to shorten filtration times, reduce virus-breakthrough risk, and maintain strong protein and virus-removal performance without a prefilter; the FG1 is compatible with standard CIP/SIP processes and entered mass production in smaller sizes, with larger formats planned to support scale-up and enable higher throughput and faster cycle times for biomanufacturers.

What Are Latest Mergers And Acquisitions In The Viral Clearance Market?

In August 2024, Merck Group, a Germany-based healthcare company, acquired Mirus Bio LLC for $600 million. This acquisition of Mirus Bio boosts its viral vector manufacturing capabilities by adding leading transfection technology, enhancing its ability to deliver integrated solutions for the expanding gene therapy market. Mirus Bio LLC is a US-based pharmaceutical company that specializes in transfection reagents for viral clearance.

What Defines the Viral Clearance Market?

The viral clearance market consists of revenues earned by entities by providing services such as viral removal and inactivation testing, validation studies, and regulatory consulting. The market value includes the value of related goods sold by the service provider or included within the service offering. The viral clearance market also includes sales of viral filters, reagents, and specialized clearance equipment. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Viral Clearance Market Report 2026?

The viral clearance market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the viral clearance industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.